DGX
Quest Diagnostics IncorporatedNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$21.50B
P/E Ratio
21.46
EPS
$9.05
Beta
0.65
52W High
$212.58
52W Low
$162.47
50-Day MA
$199.29
200-Day MA
$186.28
Dividend Yield
1.72%
Profit Margin
9.08%
Forward P/E
17.67
PEG Ratio
1.46
About Quest Diagnostics Incorporated
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Fundamentals
| Revenue (TTM) | $11.28B |
| Gross Profit (TTM) | $3.75B |
| EBITDA | $2.23B |
| Operating Margin | 14.20% |
| Return on Equity | 14.50% |
| Return on Assets | 6.35% |
| Revenue/Share (TTM) | $101.83 |
| Book Value | $66.36 |
| Price-to-Book | 2.85 |
| Price-to-Sales (TTM) | 1.91 |
| EV/Revenue | 2.391 |
| EV/EBITDA | 12.13 |
| Quarterly Earnings Growth (YoY) | 15.50% |
| Quarterly Revenue Growth (YoY) | 9.20% |
| Shares Outstanding | $110.70M |
| Float | $110.08M |
| % Insiders | 0.42% |
| % Institutions | 99.37% |
Historical Volatility
HV 10-Day
36.08%
HV 20-Day
28.99%
HV 30-Day
24.41%
HV 60-Day
26.19%
HV Rank
61.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($223.12 target)
2
Strong Buy7
Buy9
HoldData last updated: 5/1/2026